synovitis: ['Inflammation of the SYNOVIAL MEMBRANE [ MeSH ]']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
215 |
4. Check minimum number of eventsNone |
215 |
5. Include endpointsNone |
215 |
6. Filter based on genotype QC (FinnGen only) |
215 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M65
- Name in latin
- Abscessus vaginae tendinis
Similar endpoints
↥List of similar endpoints to
Abscess of tendon sheath
based on the number of shared cases.
Similar with more cases:
- Disorders of synovium and tendon
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1425 | 675 | 749 |
| Only index persons | 1365 | 650 | 715 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 48.93 | 51.37 | 46.74 |
| Only index persons | 48.50 | 51.08 | 46.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 215 | 126 | 89 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 52.12 | 48.87 | 56.72 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 188
- Matched controls
- 1879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M65.0
ICD-10 Finland
Abscess of tendon sheath
+∞
272.0
188
*
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
50.3
46
*
NDS00
NOMESCO Finland
Incision and debridement of infection of tendon of wrist or hand
+∞
42.3
39
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
30.9
22.1
29
11
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
86.5
21.2
23
*
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
26.0
19.7
27
12
WX204
NOMESCO Finland
Axillary plexus blockaced
21.7
19.3
28
15
M65.3
ICD-10 Finland
Trigger finger
30.2
18.3
24
9
M75.1
ICD-10 Finland
Rotator cuff syndrome
5.4
16.3
54
130
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
17.8
16.2
25
16
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.9
16.1
42
75
N03AX16
ATC
pregabalin; oral
4.6
15.9
64
190
ACC51
NOMESCO Finland
Release of median nerve
9.7
15.5
32
39
WX203
NOMESCO Finland
Infraclavicular plexus blockade
18.0
13.8
21
13
M79.6
ICD-10 Finland
Pain in limb
3.7
13.7
72
267
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
6.7
13.4
35
62
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
43.4
13.4
16
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
12.1
102
522
ZXA00
NOMESCO Finland
Right side
3.4
11.9
69
271
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
14.9
11.7
19
14
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
9.0
11.5
24
30
J01FF01
ATC
clindamycin; systemic
3.3
11.4
70
286
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
26.9
11.3
15
6
N02AX02
ATC
tramadol; systemic, rectal
3.0
11.2
90
442
S18
ICPC
Laceration/cut
2.9
11.0
94
479
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
116.1
10.5
11
*
NBG10
NOMESCO Finland
Acromioplastia
+∞
10.5
10
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
6.3
10.5
28
51
R4120
NOMESCO Finland
Occupational therapy
6.3
10.5
28
51
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
25.0
10.4
14
6
M01AH05
ATC
etoricoxib; oral
2.8
10.3
119
718
J01DB01
ATC
cefalexin; oral
3.7
9.8
166
1261
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
9.4
50
179
N03AX12
ATC
gabapentin; oral
4.1
9.4
38
109
M01AE02
ATC
naproxen; oral, rectal
2.6
9.3
117
724
M79.7
ICD-10 Finland
Fibromyalgia
17.3
8.7
13
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.3
8.6
26
55
M65.1
ICD-10 Finland
Other infective (teno)synovitis
+∞
8.4
8
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
15.4
8.3
13
9
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
8.1
74
373
A46
ICD-10 Finland
Erysipelas
3.7
8.0
36
113
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.6
8.0
37
119
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
7.8
104
637
N06AX21
ATC
duloxetine; oral
4.4
7.8
28
72
N02BE01
ATC
paracetamol; systemic, rectal
3.2
7.8
165
1303
R4110
NOMESCO Finland
Physiotherapy
2.6
7.3
60
285
M79.0
ICD-10 Finland
Rheumatism, unspecified
31.3
7.2
9
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
9.3
7.2
14
16
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.0
7.2
22
48
M01AE03
ATC
ketoprofen; systemic, rectal
2.4
7.2
76
411
M48.0
ICD-10 Finland
Spinal stenosis
4.0
7.1
28
79
A02BC02
ATC
pantoprazole; systemic
2.3
7.0
126
874
ZXA05
NOMESCO Finland
Left side
2.7
7.0
53
237
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.4
6.9
24
60
X58
ICD-10 Finland
Exposure to other specified factors
3.4
6.8
34
116
NDQ20
NOMESCO Finland
Amputation of finger
41.6
6.8
8
*
M01AB05
ATC
diclofenac; systemic, rectal
2.3
6.8
126
884
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.2
6.8
20
42
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
23.5
6.7
9
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
23.5
6.7
9
*
M03BX02
ATC
tizanidine; oral
2.3
6.7
121
835
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
10.6
6.6
12
12
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
10.6
6.6
12
12
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
5.3
6.6
19
39
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
7.0
6.5
15
23
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
72.1
6.5
7
*
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
72.1
6.5
7
*
NDL52
NOMESCO Finland
Tenosynovectomy of hand
72.1
6.5
7
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.6
6.4
13
16
L12
ICPC
Hand/finger symptom/complaint
3.3
6.3
31
105
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.1
6.3
16
28
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
+∞
6.3
6
*
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
+∞
6.3
6
*
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
27.7
6.3
8
*
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
27.7
6.3
8
*
M10.9
ICD-10 Finland
Gout, unspecified
4.7
6.3
20
46
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
8.1
6.2
13
17
M77.1
ICD-10 Finland
Lateral epicondylitis
4.9
6.2
19
42
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
9.1
6.1
12
14
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.1
6.1
12
14
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.1
6.1
23
62
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
10.5
6.1
11
11
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.5
6.1
11
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
6.0
27
85
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
22
21
11.56
20.34
1.6
1.4
—
—
—
0
0
88
378
3.25
15.32
3.5
2.7
336.8
9836.3
umol/l
2.41
82
326
23
36
7.03
14.41
2.3
1.4
—
—
—
0
0
60
261
2.80
9.62
1.3
1.2
15.1
28.6
iu/ml
1.13
16
77
123
780
2.35
8.57
9.2
6.6
1.2
1.2
mmol/l
0.02
107
671
120
767
2.28
8.03
4.6
3.9
—
—
—
0
0
107
657
2.25
7.84
2.4
2.1
79.5
76.9
nmol/l
0.31
99
592
166
1229
2.54
7.73
5.3
3.6
13.5
11.3
mm/h
1.21
159
1128
139
969
2.23
7.21
5.7
4.7
7.2
6.7
mmol/l
1.32
132
902
12
21
5.99
6.66
2.5
3.0
16.5
16.2
%
—
7
14
137
975
2.12
6.41
10.0
9.5
4.5
4.1
e9/l
1.16
127
857
84
500
2.12
6.34
3.1
2.1
63.0
57.6
u/l
0.30
79
461
38
160
2.67
6.32
5.4
3.1
—
—
—
0
0
69
385
2.17
6.12
2.4
2.2
—
—
—
0
0
44
203
2.47
6.07
4.5
2.1
22.8
24.0
%
0.26
37
177
123
852
2.04
6.06
6.2
6.8
10.6
10.8
umol/l
0.09
117
819
50
245
2.36
6.04
1.4
1.2
15.2
7.6
u/ml
0.26
20
88
166
1304
2.20
5.58
10.7
7.4
81.0
75.8
u/l
0.68
160
1222
87
556
1.95
5.19
3.6
2.8
—
—
—
0
0
36
163
2.45
5.14
1.9
1.8
—
—
—
0
0
73
441
1.99
5.11
3.2
2.7
0.3
0.5
e6/l
0.61
58
320
36
164
2.44
5.07
1.9
1.9
—
—
—
0
0
47
242
2.21
5.00
1.8
1.9
—
—
—
0
0
117
833
1.89
4.96
3.9
3.2
0.0
0.0
estimate
0.00
28
147
12
28
4.48
4.89
1.5
1.2
—
—
—
0
0
199
1724
3.07
4.86
25.7
12.2
25.4
24.0
mg/l
0.27
182
1338
27
109
2.69
4.85
1.8
1.4
—
—
—
0
0
49
263
2.12
4.68
2.7
2.5
1.1
1.3
e6/l
0.10
29
141
21
76
2.95
4.60
5.6
8.1
24.1
25.1
mmol/l
0.75
21
76
91
610
1.85
4.56
2.3
1.8
93.0
95.4
pmol/l
0.20
49
305
114
820
1.83
4.54
3.9
3.2
0.0
0.0
estimate
0.00
31
157
57
328
2.00
4.51
2.0
1.6
0.9
1.2
mg/l
1.20
44
255
113
824
1.78
4.19
5.3
4.5
0.0
0.0
estimate
0.00
32
159
60
362
1.91
4.10
3.0
1.9
2.7
3.0
mg/l
0.63
55
311
103
736
1.77
4.05
4.4
2.5
151.7
130.4
ug/l
0.40
90
677
44
239
2.06
4.05
2.9
2.6
1.5
2.4
e6/l
0.61
24
119
57
344
1.89
3.88
1.7
1.4
20.7
20.4
nmol/l
0.04
50
293
14
44
3.33
3.85
1.3
1.1
—
—
—
0
0
14
44
3.33
3.85
1.3
1.1
—
—
—
0
0
191
1681
2.22
3.46
20.9
11.1
81.2
83.0
ml/min/173m2
0.40
154
1355
41
230
1.97
3.43
2.6
1.8
31.4
29.2
s
1.39
41
222
13
42
3.23
3.43
2.4
2.6
—
—
—
0
0
20
83
2.55
3.42
1.5
1.3
—
—
—
0
0
21
90
2.48
3.37
10.0
10.3
94.7
94.6
%
0.05
21
90
57
360
1.79
3.32
1.4
1.2
4.3
1.7
u/ml
0.30
14
93
26
127
2.19
3.12
6.3
4.1
1.2
1.2
mmol/l
0.54
26
114
139
1128
1.66
3.08
2.9
3.2
—
—
—
0
0
156
1307
1.71
3.04
5.0
3.6
14.1
14.7
pmol/l
2.79
149
1183
24
115
2.22
3.02
6.3
2.9
150.7
75.1
ng/l
1.69
19
104
50
312
1.79
3.01
1.8
1.7
435.8
426.7
pmol/l
0.09
44
274
75
525
1.66
2.98
2.4
3.4
2.3
2.4
mmol/l
0.27
67
469
14
53
2.76
2.85
1.1
1.4
—
—
—
0
0
205
1892
2.80
2.76
24.8
14.2
83.9
75.7
umol/l
1.35
205
1892
46
288
1.76
2.73
5.5
3.5
55.0
320.6
ng/l
1.66
34
226
42
256
1.80
2.72
1.7
1.6
1395.7
1195.7
nmol/l
0.45
32
190
49
313
1.73
2.71
1.8
1.5
—
—
—
0
0
7
15
4.78
2.62
1.3
1.1
—
—
—
0
0
143
1197
1.58
2.55
3.9
2.8
51.4
45.8
u/l
0.38
132
1135
12
45
2.77
2.49
1.0
1.2
—
—
—
0
0
18
83
2.28
2.49
1.4
1.8
—
—
—
0
0
31
178
1.87
2.43
3.6
2.8
5.9
8.3
umol/l
0.84
22
159
11
40
2.84
2.41
1.7
1.6
—
—
—
0
0
61
427
1.60
2.36
3.5
3.3
2761.3
1094.5
ng/l
0.70
54
363
9
29
3.19
2.25
1.6
1.1
—
—
—
0
0
9
29
3.19
2.25
1.6
1.1
—
—
—
0
0
12
48
2.59
2.22
3.8
2.2
148.3
216.1
ug/l
0.64
12
48
14
61
2.39
2.19
1.2
1.4
115.0
239.7
miu/ml
—
6
32
196
1803
1.99
2.19
5.5
4.5
2.7
2.8
mmol/l
0.60
188
1672
194
1780
1.92
2.16
4.8
4.1
4.7
4.7
mmol/l
0.01
184
1670
30
177
1.81
2.16
8.9
7.9
5.2
5.1
kpa
0.10
30
171
30
177
1.81
2.16
8.9
7.9
11.3
12.6
kpa
0.83
30
172
204
1907
2.36
2.13
14.6
9.5
26.9
26.2
u/l
0.24
199
1838
14
62
2.35
2.12
1.6
1.6
—
—
—
0
0
61
438
1.55
2.10
4.3
3.3
0.0
0.0
estimate
0.50
30
152
12
50
2.48
2.06
2.5
1.9
44.5
1889.4
u/l
—
5
15
178
1601
1.65
2.05
6.2
4.3
1.9
1.9
mu/l
0.28
167
1457
15
70
2.23
2.03
1.9
2.6
36.7
38.0
u/l
0.08
15
64
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
192
1771
1.79
1.89
4.6
4.1
1.5
1.5
mmol/l
0.03
181
1647
25
147
1.79
1.83
3.0
2.1
53.6
30.3
u/l
0.39
19
131
42
285
1.59
1.83
2.8
2.8
2.5
2.4
mmol/l
0.14
37
257
17
88
2.01
1.80
1.1
1.0
—
—
—
0
0
11
48
2.36
1.73
2.9
1.6
—
—
—
0
0
84
670
1.42
1.66
4.0
3.2
—
—
—
0
0
5
14
3.63
1.62
1.2
1.6
—
—
—
0
0
8
32
2.56
1.61
1.5
1.2
—
—
—
0
0
11
50
2.26
1.60
1.5
1.5
—
—
—
0
0
16
86
1.93
1.55
1.4
1.3
—
—
—
0
0
75
593
1.41
1.54
5.6
3.5
29.0
34.8
ng/l
0.34
60
399
179
1648
1.51
1.47
25.5
12.8
39.6
40.2
%
0.53
135
1234
5
16
3.17
1.44
2.0
1.5
—
—
—
0
0
6
23
2.65
1.37
1.0
1.0
1.6
1.5
g/l
—
6
18
21
130
1.68
1.32
2.2
2.6
54.2
63.2
ml/min/173m2
0.52
13
56
8
36
2.27
1.25
1.3
1.0
—
—
—
0
0
8
37
2.21
1.23
1.0
1.2
—
11.7
—
0
10
5
19
2.67
1.22
1.0
1.2
5.7
3.9
mmol/l
—
5
19
184
1721
1.48
1.21
4.3
3.7
1.4
1.3
mmol/l
2.07
171
1597
11
58
1.94
1.14
1.7
1.5
—
—
—
0
0
5
23
2.20
0.98
2.0
1.7
—
—
—
0
0
10
54
1.89
0.98
1.4
1.3
—
—
—
0
0
13
79
1.69
0.90
3.6
2.3
0.6
0.7
%
0.79
13
79
25
179
1.45
0.89
2.2
2.1
—
—
—
0
0
6
31
1.96
0.85
3.7
9.0
—
142.9
—
0
7
13
82
1.62
0.80
3.6
2.3
1.1
1.2
%
0.20
13
82
180
1708
1.33
0.79
5.1
4.1
6.2
5.9
mmol/l
1.29
170
1563
26
195
1.38
0.74
2.4
2.2
—
—
—
0
0
5
25
2.02
0.73
1.6
1.7
—
—
—
0
0
5
28
1.80
0.66
2.0
1.7
—
—
—
0
0
5
30
1.68
0.62
1.6
2.0
—
—
—
0
0
13
90
1.47
0.57
2.2
1.8
—
—
—
0
0
54
466
1.21
0.55
1.7
1.6
1.4
1.4
mmol/l
0.21
48
392
14
100
1.43
0.53
5.1
6.8
26.5
24.8
mmol/l
2.06
14
94
5
32
1.58
0.42
2.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
2.4
—
12.9
—
0
17
5
35
1.44
0.39
1.8
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
2.5
—
74.7
—
0
19
22
180
1.25
0.37
1.6
1.7
—
—
—
0
0
5
37
1.36
0.37
1.4
1.3
—
—
—
0
0
6
44
1.37
0.34
1.8
1.8
—
—
—
0
0
6
45
1.34
0.34
1.8
1.8
—
—
—
0
0
56
512
1.13
0.29
4.5
4.8
1.3
2.8
ug/l
1.66
48
457
33
293
1.15
0.26
2.4
3.1
0.5
0.8
ug/l
2.90
16
183
14
114
1.24
0.26
2.1
1.9
—
—
—
0
0
34
305
1.14
0.23
1.3
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
21
184
1.16
0.20
9.2
6.5
—
—
—
0
0
6
52
1.16
0.19
1.5
1.5
—
—
—
0
0
18
201
0.89
0.14
4.8
4.0
32.1
31.7
%
0.05
12
131
5
44
1.14
0.10
1.2
1.7
—
—
—
0
0
5
60
0.83
0.08
1.2
1.4
45.4
41.4
nmol/l
—
5
60
7
68
1.03
0.08
1.1
1.4
—
—
—
0
0
41
401
1.03
0.02
4.0
4.3
23.3
20.8
%
0.35
13
180
19
185
1.03
0.00
3.2
4.6
1.9
7.9
ug/l
1.78
12
153
5
54
0.92
0.00
2.4
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
110.2
—
0
6
6
59
1.02
0.00
1.3
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
8.3
—
0
7
0
6
0.00
0.00
0.0
1.0
—
23.2
—
0
6
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
8
85
0.94
0.00
2.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
64
0.94
0.00
1.3
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_ABSCTENDON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_ABSCTENDON | 1.179 [0.9, 1.55] | 0.235 |
| Birth year | 0.999 [0.99, 1.01] | 0.723 |
During the follow-up period (1.1.1998 — 31.12.2019), 76 out of 589 females with M13_ABSCTENDON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_ABSCTENDON | 1.623 [1.22, 2.17] | 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 624 males with M13_ABSCTENDON died.
Mortality risk
Mortality risk for people of age
years, who have M13_ABSCTENDON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.108% | 0.294% |
| 5 | 0.704% | 1.659% |
| 10 | 1.838% | 4.204% |
| 15 | 3.309% | 8.465% |
| 20 | 6.222% | 14.247% |
Relationships between endpoints
↥Index endpoint: M13_ABSCTENDON – Abscess of tendon sheath
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data